Published in Medical Letter on the CDC and FDA, July 6th, 2008
The Athletes for Life Foundation has selected Signalife's award winning technology to perform heart monitoring and screening as part of the program's activities. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.